nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—Neoplasm—Methotrexate—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Mitotane—Anaemia—Mycophenolic acid—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Mitotane—Somnolence—Captopril—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Mitotane—Gynaecomastia—Methotrexate—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Mitotane—Dyspepsia—Captopril—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Mitotane—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Mitotane—Mental disorder—Lisinopril—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Mitotane—Lethargy—Prednisone—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Mitotane—Dizziness—Pentoxifylline—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Mitotane—Hypertension—Leflunomide—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Mitotane—Decreased appetite—Captopril—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Mitotane—Malnutrition—Lisinopril—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Mitotane—Infection—Azathioprine—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Mitotane—Vertigo—Mycophenolic acid—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Mitotane—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Mitotane—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Mitotane—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Mitotane—Osteoarthritis—Prednisone—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Mitotane—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Mitotane—Dysgeusia—Lisinopril—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Mitotane—Skin disorder—Azathioprine—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Mitotane—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Mitotane—Vomiting—Pentoxifylline—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Mitotane—Rash—Pentoxifylline—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Mitotane—Hypertension—Mycophenolic acid—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Mitotane—Dermatitis—Pentoxifylline—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Mitotane—Headache—Pentoxifylline—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Mitotane—Feeling abnormal—Captopril—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Mitotane—Infection—Leflunomide—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Mitotane—Vision blurred—Lisinopril—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Mitotane—Asthenia—Mometasone—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Mitotane—Irritability—Prednisone—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Mitotane—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Mitotane—Hypotension—Azathioprine—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Mitotane—Tremor—Lisinopril—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Mitotane—Nervous system disorder—Leflunomide—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Mitotane—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Mitotane—Anaemia—Lisinopril—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Mitotane—Skin disorder—Leflunomide—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Mitotane—Confusional state—Mycophenolic acid—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Mitotane—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Mitotane—Body temperature increased—Captopril—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Mitotane—Anorexia—Leflunomide—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Mitotane—Nausea—Pentoxifylline—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Mitotane—Infection—Mycophenolic acid—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Mitotane—Vertigo—Lisinopril—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Mitotane—Diarrhoea—Mometasone—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Mitotane—Shock—Mycophenolic acid—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Mitotane—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Mitotane—Hypotension—Leflunomide—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Mitotane—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Mitotane—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Mitotane—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Mitotane—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Mitotane—Muscular weakness—Prednisone—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Mitotane—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Mitotane—Anorexia—Mycophenolic acid—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Mitotane—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Mitotane—Paraesthesia—Leflunomide—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Mitotane—Hypotension—Mycophenolic acid—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Mitotane—Lethargy—Methotrexate—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Mitotane—Dyspepsia—Leflunomide—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Mitotane—Vomiting—Mometasone—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Mitotane—Feeling abnormal—Azathioprine—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Mitotane—Rash—Mometasone—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Mitotane—Asthenia—Captopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Mitotane—Dermatitis—Mometasone—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Mitotane—Decreased appetite—Leflunomide—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Mitotane—Osteoarthritis—Methotrexate—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Mitotane—Confusional state—Lisinopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Mitotane—Headache—Mometasone—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Mitotane—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Mitotane—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Mitotane—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Mitotane—Pain—Leflunomide—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Mitotane—Infection—Lisinopril—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Mitotane—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Mitotane—Somnolence—Mycophenolic acid—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Mitotane—Shock—Lisinopril—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Mitotane—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Mitotane—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Mitotane—Neutropenia—Prednisone—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Mitotane—Body temperature increased—Azathioprine—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Mitotane—Skin disorder—Lisinopril—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Mitotane—Diarrhoea—Captopril—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Mitotane—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Mitotane—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Mitotane—Irritability—Methotrexate—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Mitotane—Feeling abnormal—Leflunomide—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Mitotane—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Mitotane—Nausea—Mometasone—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Mitotane—Anorexia—Lisinopril—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Mitotane—Ataxia—Methotrexate—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Mitotane—Pain—Mycophenolic acid—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Mitotane—Hypotension—Lisinopril—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Mitotane—Dizziness—Captopril—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Mitotane—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Mitotane—Body temperature increased—Leflunomide—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Mitotane—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Mitotane—Breast disorder—Methotrexate—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Mitotane—Hypersensitivity—Azathioprine—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Mitotane—Paraesthesia—Lisinopril—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Mitotane—Vomiting—Captopril—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Mitotane—Rash—Captopril—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Mitotane—Dermatitis—Captopril—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Mitotane—Somnolence—Lisinopril—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Mitotane—Headache—Captopril—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Mitotane—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Mitotane—Dyspepsia—Lisinopril—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Mitotane—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Mitotane—Infection—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Mitotane—Decreased appetite—Lisinopril—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Mitotane—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Mitotane—Shock—Mycophenolate mofetil—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Mitotane—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Mitotane—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Mitotane—Hypersensitivity—Leflunomide—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Mitotane—Pain—Lisinopril—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Mitotane—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Mitotane—Diarrhoea—Azathioprine—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Mitotane—Nausea—Captopril—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Mitotane—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Mitotane—Asthenia—Leflunomide—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Mitotane—Feeling abnormal—Lisinopril—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Mitotane—Connective tissue disorder—Prednisone—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Mitotane—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Mitotane—Neutropenia—Methotrexate—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Mitotane—Dizziness—Azathioprine—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Mitotane—Asthenia—Mycophenolic acid—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Mitotane—Diarrhoea—Leflunomide—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Mitotane—Body temperature increased—Lisinopril—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Mitotane—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Mitotane—Vomiting—Azathioprine—systemic scleroderma	0.001	0.001	CcSEcCtD
Mitotane—Eye disorder—Prednisone—systemic scleroderma	0.000998	0.000998	CcSEcCtD
Mitotane—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000995	0.000995	CcSEcCtD
Mitotane—Infestation NOS—Methotrexate—systemic scleroderma	0.000995	0.000995	CcSEcCtD
Mitotane—Infestation—Methotrexate—systemic scleroderma	0.000995	0.000995	CcSEcCtD
Mitotane—Drowsiness—Methotrexate—systemic scleroderma	0.000995	0.000995	CcSEcCtD
Mitotane—Rash—Azathioprine—systemic scleroderma	0.000993	0.000993	CcSEcCtD
Mitotane—Dermatitis—Azathioprine—systemic scleroderma	0.000992	0.000992	CcSEcCtD
Mitotane—Flushing—Prednisone—systemic scleroderma	0.000991	0.000991	CcSEcCtD
Mitotane—Headache—Azathioprine—systemic scleroderma	0.000987	0.000987	CcSEcCtD
Mitotane—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000986	0.000986	CcSEcCtD
Mitotane—Dizziness—Leflunomide—systemic scleroderma	0.000983	0.000983	CcSEcCtD
Mitotane—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000973	0.000973	CcSEcCtD
Mitotane—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000971	0.000971	CcSEcCtD
Mitotane—Angiopathy—Prednisone—systemic scleroderma	0.000969	0.000969	CcSEcCtD
Mitotane—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000967	0.000967	CcSEcCtD
Mitotane—Pain—Mycophenolate mofetil—systemic scleroderma	0.000957	0.000957	CcSEcCtD
Mitotane—Haematuria—Methotrexate—systemic scleroderma	0.000948	0.000948	CcSEcCtD
Mitotane—Vomiting—Leflunomide—systemic scleroderma	0.000946	0.000946	CcSEcCtD
Mitotane—Hypersensitivity—Lisinopril—systemic scleroderma	0.000941	0.000941	CcSEcCtD
Mitotane—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000941	0.000941	CcSEcCtD
Mitotane—Dizziness—Mycophenolic acid—systemic scleroderma	0.000938	0.000938	CcSEcCtD
Mitotane—Rash—Leflunomide—systemic scleroderma	0.000938	0.000938	CcSEcCtD
Mitotane—Dermatitis—Leflunomide—systemic scleroderma	0.000937	0.000937	CcSEcCtD
Mitotane—Mental disorder—Prednisone—systemic scleroderma	0.000936	0.000936	CcSEcCtD
Mitotane—Nausea—Azathioprine—systemic scleroderma	0.000935	0.000935	CcSEcCtD
Mitotane—Headache—Leflunomide—systemic scleroderma	0.000932	0.000932	CcSEcCtD
Mitotane—Malnutrition—Prednisone—systemic scleroderma	0.00093	0.00093	CcSEcCtD
Mitotane—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000923	0.000923	CcSEcCtD
Mitotane—Asthenia—Lisinopril—systemic scleroderma	0.000917	0.000917	CcSEcCtD
Mitotane—Vomiting—Mycophenolic acid—systemic scleroderma	0.000902	0.000902	CcSEcCtD
Mitotane—Rash—Mycophenolic acid—systemic scleroderma	0.000895	0.000895	CcSEcCtD
Mitotane—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000894	0.000894	CcSEcCtD
Mitotane—Hepatitis—Methotrexate—systemic scleroderma	0.000893	0.000893	CcSEcCtD
Mitotane—Headache—Mycophenolic acid—systemic scleroderma	0.000889	0.000889	CcSEcCtD
Mitotane—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000885	0.000885	CcSEcCtD
Mitotane—Nausea—Leflunomide—systemic scleroderma	0.000883	0.000883	CcSEcCtD
Mitotane—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000882	0.000882	CcSEcCtD
Mitotane—Vision blurred—Prednisone—systemic scleroderma	0.000876	0.000876	CcSEcCtD
Mitotane—Urethral disorder—Methotrexate—systemic scleroderma	0.000875	0.000875	CcSEcCtD
Mitotane—Diarrhoea—Lisinopril—systemic scleroderma	0.000874	0.000874	CcSEcCtD
Mitotane—Visual impairment—Methotrexate—systemic scleroderma	0.00086	0.00086	CcSEcCtD
Mitotane—Anaemia—Prednisone—systemic scleroderma	0.00086	0.00086	CcSEcCtD
Mitotane—Dizziness—Lisinopril—systemic scleroderma	0.000845	0.000845	CcSEcCtD
Mitotane—Nausea—Mycophenolic acid—systemic scleroderma	0.000843	0.000843	CcSEcCtD
Mitotane—Vertigo—Prednisone—systemic scleroderma	0.000835	0.000835	CcSEcCtD
Mitotane—Eye disorder—Methotrexate—systemic scleroderma	0.000834	0.000834	CcSEcCtD
Mitotane—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000825	0.000825	CcSEcCtD
Mitotane—Vomiting—Lisinopril—systemic scleroderma	0.000812	0.000812	CcSEcCtD
Mitotane—Angiopathy—Methotrexate—systemic scleroderma	0.00081	0.00081	CcSEcCtD
Mitotane—Rash—Lisinopril—systemic scleroderma	0.000806	0.000806	CcSEcCtD
Mitotane—Dermatitis—Lisinopril—systemic scleroderma	0.000805	0.000805	CcSEcCtD
Mitotane—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000803	0.000803	CcSEcCtD
Mitotane—Hypertension—Prednisone—systemic scleroderma	0.000803	0.000803	CcSEcCtD
Mitotane—Headache—Lisinopril—systemic scleroderma	0.000801	0.000801	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000786	0.000786	CcSEcCtD
Mitotane—Mental disorder—Methotrexate—systemic scleroderma	0.000782	0.000782	CcSEcCtD
Mitotane—Malnutrition—Methotrexate—systemic scleroderma	0.000777	0.000777	CcSEcCtD
Mitotane—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000766	0.000766	CcSEcCtD
Mitotane—Dysgeusia—Methotrexate—systemic scleroderma	0.000761	0.000761	CcSEcCtD
Mitotane—Nausea—Lisinopril—systemic scleroderma	0.000759	0.000759	CcSEcCtD
Mitotane—Infection—Prednisone—systemic scleroderma	0.000754	0.000754	CcSEcCtD
Mitotane—Shock—Prednisone—systemic scleroderma	0.000747	0.000747	CcSEcCtD
Mitotane—Nervous system disorder—Prednisone—systemic scleroderma	0.000744	0.000744	CcSEcCtD
Mitotane—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00074	0.00074	CcSEcCtD
Mitotane—Skin disorder—Prednisone—systemic scleroderma	0.000737	0.000737	CcSEcCtD
Mitotane—Vision blurred—Methotrexate—systemic scleroderma	0.000732	0.000732	CcSEcCtD
Mitotane—Anorexia—Prednisone—systemic scleroderma	0.000723	0.000723	CcSEcCtD
Mitotane—Anaemia—Methotrexate—systemic scleroderma	0.000718	0.000718	CcSEcCtD
Mitotane—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000712	0.000712	CcSEcCtD
Mitotane—Rash—Mycophenolate mofetil—systemic scleroderma	0.000706	0.000706	CcSEcCtD
Mitotane—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000705	0.000705	CcSEcCtD
Mitotane—Headache—Mycophenolate mofetil—systemic scleroderma	0.000701	0.000701	CcSEcCtD
Mitotane—Vertigo—Methotrexate—systemic scleroderma	0.000698	0.000698	CcSEcCtD
Mitotane—Paraesthesia—Prednisone—systemic scleroderma	0.000681	0.000681	CcSEcCtD
Mitotane—Dyspepsia—Prednisone—systemic scleroderma	0.000668	0.000668	CcSEcCtD
Mitotane—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000665	0.000665	CcSEcCtD
Mitotane—Decreased appetite—Prednisone—systemic scleroderma	0.00066	0.00066	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000657	0.000657	CcSEcCtD
Mitotane—Confusional state—Methotrexate—systemic scleroderma	0.00064	0.00064	CcSEcCtD
Mitotane—Infection—Methotrexate—systemic scleroderma	0.00063	0.00063	CcSEcCtD
Mitotane—Feeling abnormal—Prednisone—systemic scleroderma	0.000625	0.000625	CcSEcCtD
Mitotane—Nervous system disorder—Methotrexate—systemic scleroderma	0.000622	0.000622	CcSEcCtD
Mitotane—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000621	0.000621	CcSEcCtD
Mitotane—Skin disorder—Methotrexate—systemic scleroderma	0.000616	0.000616	CcSEcCtD
Mitotane—Anorexia—Methotrexate—systemic scleroderma	0.000605	0.000605	CcSEcCtD
Mitotane—Body temperature increased—Prednisone—systemic scleroderma	0.0006	0.0006	CcSEcCtD
Mitotane—Hypotension—Methotrexate—systemic scleroderma	0.000593	0.000593	CcSEcCtD
Mitotane—Paraesthesia—Methotrexate—systemic scleroderma	0.00057	0.00057	CcSEcCtD
Mitotane—Somnolence—Methotrexate—systemic scleroderma	0.000564	0.000564	CcSEcCtD
Mitotane—Hypersensitivity—Prednisone—systemic scleroderma	0.000559	0.000559	CcSEcCtD
Mitotane—Dyspepsia—Methotrexate—systemic scleroderma	0.000558	0.000558	CcSEcCtD
Mitotane—Decreased appetite—Methotrexate—systemic scleroderma	0.000551	0.000551	CcSEcCtD
Mitotane—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000548	0.000548	CcSEcCtD
Mitotane—Asthenia—Prednisone—systemic scleroderma	0.000545	0.000545	CcSEcCtD
Mitotane—Pain—Methotrexate—systemic scleroderma	0.000542	0.000542	CcSEcCtD
Mitotane—Feeling abnormal—Methotrexate—systemic scleroderma	0.000523	0.000523	CcSEcCtD
Mitotane—Diarrhoea—Prednisone—systemic scleroderma	0.000519	0.000519	CcSEcCtD
Mitotane—Dizziness—Prednisone—systemic scleroderma	0.000502	0.000502	CcSEcCtD
Mitotane—Body temperature increased—Methotrexate—systemic scleroderma	0.000501	0.000501	CcSEcCtD
Mitotane—Vomiting—Prednisone—systemic scleroderma	0.000483	0.000483	CcSEcCtD
Mitotane—Rash—Prednisone—systemic scleroderma	0.000479	0.000479	CcSEcCtD
Mitotane—Dermatitis—Prednisone—systemic scleroderma	0.000478	0.000478	CcSEcCtD
Mitotane—Headache—Prednisone—systemic scleroderma	0.000475	0.000475	CcSEcCtD
Mitotane—Hypersensitivity—Methotrexate—systemic scleroderma	0.000467	0.000467	CcSEcCtD
Mitotane—Asthenia—Methotrexate—systemic scleroderma	0.000455	0.000455	CcSEcCtD
Mitotane—Nausea—Prednisone—systemic scleroderma	0.000451	0.000451	CcSEcCtD
Mitotane—Diarrhoea—Methotrexate—systemic scleroderma	0.000434	0.000434	CcSEcCtD
Mitotane—Dizziness—Methotrexate—systemic scleroderma	0.000419	0.000419	CcSEcCtD
Mitotane—Vomiting—Methotrexate—systemic scleroderma	0.000403	0.000403	CcSEcCtD
Mitotane—Rash—Methotrexate—systemic scleroderma	0.0004	0.0004	CcSEcCtD
Mitotane—Dermatitis—Methotrexate—systemic scleroderma	0.0004	0.0004	CcSEcCtD
Mitotane—Headache—Methotrexate—systemic scleroderma	0.000397	0.000397	CcSEcCtD
Mitotane—Nausea—Methotrexate—systemic scleroderma	0.000377	0.000377	CcSEcCtD
